Ann: AGM - Chairman address and CEO presentation, page-9

I've made my popcorn, should be an interesting time seeing how the market reacts.

Pretty low volume so far but nice to see the steady climb.

I'm certainly releived to not see nasties but I'm acutely aware of the big catalysts being US distributer deal and FDA decision hopefully by end of year.

I have a cynical theory that Astrazenica is waiting to see if they can snap up Starpharma for pennies in the dollar if the FDA declines Vivagel in the US, prior to them launching AZD0466. Thats my 1 wild theory of the AZD0466 delay, I dont have many other theories.